WASKYRA
LIVE

Serial Number

79430823

Owner

FONDAZIONE TELETHON ETS

Attorney

Michael J. Leonard

Filing Date

Jun 3, 2025

Add to watchlist:

No watchlists yet
View on USPTO

WASKYRA Trademark

Serial Number: 79430823 • Registration: 8182426

WASKYRA is a trademark filed by FONDAZIONE TELETHON ETS on June 3, 2025. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

FONDAZIONE TELETHON ETS (3 trademarks)

Via Varese 16/B
Roma 00185 , IT

Entity Type: 99

Trademark Details

Filing Date

June 3, 2025

Registration Date

March 24, 2026

Published for Opposition

February 3, 2026

Goods & Services

Biological research, clinical research in the field of gene therapy and medical research; medical research laboratory services; research and development of vaccines and medicines; scientific research services in the preparation of biological samples for testing and analysis in research laboratories; genetic scientific research; scientific research and development; pharmaceutical drug development services; providing information on clinical studies via an interactive website; medical and scientific research, namely, conducting clinical trials for others; DNA screening for scientific research purposes; design and development of computer hardware and software; research and development of new products for others; conducting technical scientific feasibility project studies; rental of computer software for collecting, analysing and organizing data in the field of medical research and treatment of genetic diseases; computer programming; conversion of computer programs and data, other than physical conversion; recovery of computer data; quality control for others; material testing; engineering, namely, surveying; conversion of data or documents from physical to electronic media; bacteriological research; hosting of communication computer platforms on the internet; programming of software for Internet platforms; pharmaceutical products development; scientific research services; scientific laboratory services; structural and functional analysis of genomes; development of pharmaceutical preparations and medicines; scientific research consultancy in relation to assessments, estimates, and researches in science and technology rendered by engineers; providing information in the nature of evaluations and estimations in the field of medical research; industrial research and biological analysis in the field of health; providing of imaging and physiology platforms, namely, providing temporary use of online non-downloadable software for analysing medical imaging; research and development of pharmaceuticals and veterinary and hygiene preparations for others; product development and testing of pharmaceuticals in the validation of biological tests, cellular tests, genetic tests and immunological tests; gene therapy research and scientific research

Pharmaceutical preparations for gene therapy for the treatment of Wiskott-Aldrich syndrome; medicine, namely, Etuvetidigene autotemcel; pharmaceutical preparations for treating Wiskott-Aldrich syndrome

Medical services; medical screening; medical assistance; medical counselling; providing news and information in the field of medicine; performing diagnosis of diseases; medical advisory services relating to degenerative diseases; medical surgical diagnostic services; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical diagnostic services; human hygiene and beauty care; health counselling; hospital services; nursing home services; pharmacy advice, namely, prescription management and reviews; medical imaging services; human tissue bank services; conducting of medical examinations; medical consultations; medical and health care services relating to DNA, genetics and genetic testing; telemedicine services; stem cell therapy services; preparation and dispensing of medications; providing of medical information in the pharmaceutical field; medical, alternative medicinal and pharmaceutical consultancy

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Mar 24, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Mar 24, 2026 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 3, 2026 NPUB
PUBLISHED FOR OPPOSITION
Feb 3, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 28, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 12, 2026 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 24, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 24, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 24, 2025 TROA
REFUSAL PROCESSED BY IB
Dec 18, 2025 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Dec 4, 2025 RFCS
REFUSAL PROCESSED BY MPU
Dec 4, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Oct 22, 2025 RFCR
NON-FINAL ACTION WRITTEN
Oct 21, 2025 CNRT
ASSIGNED TO EXAMINER
Oct 21, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Aug 25, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 25, 2025 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Aug 21, 2025 REPR